CIK 0001533998 · Non-accelerated filer<br>Smaller reporting company
DarioHealth Corp.
Sign in to watch- Ticker
- DRIO
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 452973162
- Phone
- 972-4-770-6377
- Business address
- 322 W 57TH ST. #33B, NEW YORK, NY, 10019
- Former names
- LabStyle Innovations Corp.
- 424B5 Offering Prospectus
- 8-K Event Material agreement · Other events
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- 8-K Event Material agreement · Results of operations
- S-8 Other Securities Offered to Employees in Benefit Plans
- 424B5 Offering Prospectus
- 8-K Event Executive or director change
- 10-Q Report Quarterly Report
- EFFECT Other Notice of Effectiveness
- 4 Open-market sale Chief Operating Officer sold 804 shares at $19.09 ($15,349)
- CORRESP Other Correspondence Between Filers and SEC Staff
- 4 Open-market sale Chief Executive Officer sold 1,000 shares at an average $19.07 ($19,073)
- 4 Open-market sale Chief Operating Officer sold 400 shares at an average $19.07 ($7,628)
- 4 Open-market sale Chief Executive Officer sold 38,340 shares at an average $18.87 ($723,385)
- 4 Open-market sale Chief Operating Officer sold 12,379 shares at an average $19.11 ($236,519)
- 4 Open-market sale Chief Executive Officer sold 67,083 shares at an average $18.41 ($1,235,189)
- UPLOAD Other SEC-generated Letter
- S-3 Offering Registration Statement
Page 13 of 46 · 905 filings